Latest Trials

EudraCT Number: 2015-003670-32 Sponsor Protocol Number: REFLECT Start Date:
Sponsor Name: Medical Center - University of Freiburg
Full Title: A dual-center prospective phase I/II trial to establish safety, tolerability and to obtain first data on efficacy of losartan in children with recessive dystrophic epidermolysis bullosa (RDEB)
Medical condition: Recessive dystrophic epidermolysis bullosa (RDEB)
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10014989 Epidermolysis bullosa PT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: DE (Completed) AT (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe